An observational study in Healthy Volunteers, Motor Deficits and Dysphagia, sponsored by National Research Center for Rehabilitation Technical Aids. Recruiting at 1 site in China. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-13.
Sponsored by National Research Center for Rehabilitation Technical Aids · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 24 studies in Neurologic Manifestations with a site in China — 11 open to participants now, 11 under way, none of them phase 3. Neurologic Manifestations · China.
Among the 24 studies in Neurologic Manifestations with a site in China, this one is the 9th largest by planned enrollment of the 10 observational ones that give a count, is the only one that started in 2019, is one of 10 observational ones, reaches primary completion later than 7 of the 10 other live ones, and was the 8th registered.
427 studies on the registry are indexed under Neurologic Manifestations; 80 are open to participants now.
Browse Neurologic Manifestations studies →11 of the 24 studies in Neurologic Manifestations with a site in China are open now. Recruiting first, the newest first:
The First Affiliated Hospital of Zhejiang Chinese Medical University · Sites in China
Ages 18+
Xiangya Hospital of Central South University · Sites in China
Healthy volunteers
Xuanwu Hospital, Beijing · Sites in China
Ages 14–65
First Affiliated Hospital of the Chinese People's Liberation Army Naval Medical University · Sites in China
Ages 20–80
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · Sites in China
Ages 18+
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 59 Neurologic Manifestations studies recruiting now, 31 (53%) set no upper age limit and 15 (25%) stop at 75 or younger; 15 take children under 18; 12 take healthy volunteers.
This study: 18 Years to 80 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
24 studies; the count open now beside each. This study's row is marked.
First in 2012; this study’s year is marked. 1 started in 2019.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 40 is below the median of 141 across 131 observational studies indexed under Neurologic Manifestations.
Median enrollment 69 across the 14 interventional studies, 231 across the 10 observational. Of the 6 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 24 have an industry lead sponsor. The 10 most frequent:
National Research Center for Rehabilitation Technical Aids is the lead sponsor of 6 studies on the registry; 5 are open to participants now.
National Research Center for Rehabilitation Technical Aids has 1 study filed under Neurologic Manifestations — fewer than ten, so there is no comparison to draw.
1 of the studies in Neurologic Manifestations with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03979235National Research Center for Rehabilitation Technical AidsDeveloping Effectiveness Evaluation and Therapeutic Programs of Rehabilitation | 2026-12 |
Add it to your calendar (.ics) → With an account.
Among the 24 studies in Neurologic Manifestations with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Using robotics, sensors, and sEMG to develop clinic-oriented quantitative effectiveness evaluation and individualized programs of rehabilitation
Using robotics, sensors, sEMG or other methods to develop clinic-oriented quantitative effectiveness evaluation and individualized programs of rehabilitation
Recruiting with advertising
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria (for healthy people):
Inclusion Criteria (for patients with motor deficits or dysphagia):
Exclusion Criteria (for patients with motor deficits or dysphagia):
perform motor function assessment by using scales, sEMG, and inertia sensors
Diagnostic Test: Motor function assessment
perform motor function assessment by using scales, sEMG, and inertia sensors
Diagnostic Test: Motor function assessment
perform motor function assessment by using scales, sEMG, and inertia sensors
Diagnostic Test: Motor function assessment
perform motor function assessment by using scales, sEMG, and inertia sensors
Motor function assessment
Fugl-Meyer Assessment
Time frame: Change from Baseline scores at 1 month
surface EMG
high-density surface EMG
Time frame: Change from Baseline status at 1 month
Kinematics test
Using inertia sensors to assess kinematics during movement
Time frame: Change from Baseline status at 1 month
Started Jun 2019 (actual). Primary completion is estimated for Dec 2026, 90 months after the start.
Of 52 non-industry observational studies under Neurologic Manifestations, half reached primary completion within 40 months of starting (the median), counting those still running; a quarter within 26 and three quarters within 339. This study's planned 90 months is above that.
Counting every sponsor, half of 59 studies reached it within 39 months; a quarter within 22 and three quarters within 339.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Research Center for Rehabilitation Technical Aids